References
- L'Heureux N, Dusserre N, Konig G, et al. First human use of a completely autologous tissue engineered blood vessel. American Heart Association Scientific Sessions. Circulation 2005; 112 (Suppl): II–632
- Battaglia L, Lucero G, Morhac M, Koziner B. Técnica de cultivo de condrocitos autólogos. Rev Arg Artroscop 2004; 10: 51–4
- Bianchi de Di Risio, CC, Callero, F, Hidalgo, A, Argibay, P. Mesenchymal stem cells. Differentiation and alternative source of neural tissue. Medicina (Buenos Aires) 2004;64:543–9, [in Spanish].
- Spyridonidis A, Bertz H, Ihorst G, et al. Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies. Blood 2005; 105: 4147–8
- Goldszmid RS, Idoyaga J, Bravo A, et al. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol 2003; 171: 5940–7
- Bertinetti, C, Simon, F, Zirlik, K , et al. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in. Escherichia coli. Eur J Haematol 2006, (Epub ahead of print August 30th, 2006‘).
- Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005; 92: 1188–92
- Spyridonidis A, Mertelsmann R, Finke J. Hematopoietic stem cell transplantation: more than just hematopoietic?. J Cancer Res Clin Oncol 2004; 130: 127–34